ALERCELL AI-powered epigenetic diagnostic platform detecting leukemia up to 41 months before clinical symptoms.
ALERCELL is headquartered in Bozeman, United States.
ALERCELL AI-powered epigenetic diagnostic platform detecting leukemia up to 41 months before clinical symptoms.
ALERCELL is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"ALERCELL — Funding & Investors." VCBacked, March 24, 2026, https://www.vcbacked.co/company/alercell. Accessed August 14, 2026.
VCBacked. (2026). ALERCELL — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/alercell
{{cite web |title=ALERCELL — Funding & Investors |url=https://www.vcbacked.co/company/alercell |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated